CDKN2A and neoplasm: The analysis of the data until now reported on the molecular characterization of Barrett’s esophagus, dysplastic lesions and EACs suggests a role for some selected genes in tumor progression: TP53, CDKN2A, CTNNB1, CDH1, GPX3 and NOX5 [32].